Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with primary liver cancer (specifically hepatocellular carcinoma or intrahepatic cholangiocarcinoma).
- People who are willing and able to sign a consent form agreeing to take part in the trial.
- People whose doctor has determined they are ready to begin their first round of systemic (whole-body) treatment for their cancer.
- People whose doctor has determined they are suitable for surgery to remove the cancer.
Who may not be able to join:
- People who have another serious health condition that means their life expectancy is less than 12 months.
- People who have an autoimmune disease (where the immune system attacks the body) or a long-term inflammatory condition.
- People who have a dependency on drugs or alcohol.
- People who currently have, or have been treated for, another cancer outside the liver within the last 3 years — though there are some exceptions, including: cancers that were fully removed with surgery and have shown no signs of returning for more than 3 years; certain treated skin cancers with no sign of spread; treated early-stage cervical cancer with no sign of return; a pre-cancerous prostate condition with no sign of invasive disease; or certain treated early-stage bladder conditions.
- People who are living with HIV infection.
- People who are unwilling or unable to cooperate with the trial, or who are not able to sign the consent form.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0382501808
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants with HCC or CCA as assessed by extraction of PBMC and infiltrating cells
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.